PBYI – Puma Biotechnology Inc.
PBYI — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
10.16
Margin Of Safety %
16
Put/Call OI Ratio
0.17
EPS Next Q Diff
0.26
EPS Last/This Y
-0.17
EPS This/Next Y
-0.1
Price
8.95
Target Price
6
Analyst Recom
3
Performance Q
22.73
Upside
-30.0%
Beta
1.22
Ticker: PBYI
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-14 | PBYI | 8.3 | 0.28 | 0.20 | 2013 |
| 2026-07-15 | PBYI | 8.4 | 0.28 | 0.00 | 2011 |
| 2026-07-16 | PBYI | 8.41 | 0.25 | 6.67 | 2219 |
| 2026-07-17 | PBYI | 8.52 | 0.25 | 13.71 | 2219 |
| 2026-07-20 | PBYI | 8.31 | 0.15 | 0.80 | 1877 |
| 2026-07-21 | PBYI | 8.57 | 0.15 | 0.00 | 1885 |
| 2026-07-22 | PBYI | 7.86 | 0.15 | 0.15 | 1936 |
| 2026-07-23 | PBYI | 8.02 | 0.15 | 0.00 | 1964 |
| 2026-07-24 | PBYI | 7.97 | 0.16 | 0.00 | 1838 |
| 2026-07-27 | PBYI | 8 | 0.17 | 0.00 | 1849 |
| 2026-07-28 | PBYI | 7.96 | 0.17 | 0.46 | 1798 |
| 2026-07-29 | PBYI | 7.8 | 0.17 | 0.46 | 1798 |
| 2026-07-30 | PBYI | 7.88 | 0.17 | 0.00 | 1798 |
| 2026-07-31 | PBYI | 7.94 | 0.17 | 0.00 | 1798 |
| 2026-08-03 | PBYI | 7.68 | 0.17 | 0.00 | 1798 |
| 2026-08-04 | PBYI | 7.81 | 0.17 | 0.00 | 1798 |
| 2026-08-05 | PBYI | 8.01 | 0.17 | 0.00 | 1798 |
| 2026-08-06 | PBYI | 8.14 | 0.17 | 0.00 | 1799 |
| 2026-08-07 | PBYI | 8.89 | 0.17 | 0.19 | 1800 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-14 | PBYI | 8.30 | -53.3 | - | 0.45 |
| 2026-07-15 | PBYI | 8.40 | -53.3 | - | 0.45 |
| 2026-07-16 | PBYI | 8.42 | -53.3 | - | 0.45 |
| 2026-07-17 | PBYI | 8.52 | -53.3 | - | 0.45 |
| 2026-07-20 | PBYI | 8.31 | -53.3 | - | 0.45 |
| 2026-07-21 | PBYI | 8.58 | -53.3 | - | 0.45 |
| 2026-07-22 | PBYI | 7.86 | -53.3 | - | 0.45 |
| 2026-07-23 | PBYI | 8.02 | -53.3 | - | 0.45 |
| 2026-07-24 | PBYI | 7.97 | -53.3 | - | 0.45 |
| 2026-07-27 | PBYI | 8.01 | -53.3 | - | 0.45 |
| 2026-07-28 | PBYI | 7.95 | -53.3 | - | 0.45 |
| 2026-07-29 | PBYI | 7.80 | -53.3 | - | 0.45 |
| 2026-07-30 | PBYI | 7.88 | -53.3 | - | 0.45 |
| 2026-07-31 | PBYI | 7.94 | -53.3 | - | 0.45 |
| 2026-08-03 | PBYI | 7.69 | -53.3 | - | 0.45 |
| 2026-08-04 | PBYI | 7.69 | -53.3 | - | 0.45 |
| 2026-08-05 | PBYI | 8.01 | -53.3 | - | 0.45 |
| 2026-08-06 | PBYI | 8.14 | -53.3 | - | 0.45 |
| 2026-08-07 | PBYI | 8.95 | -53.3 | - | 0.45 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-14 | PBYI | -1.16 | 6.34 | 9.34 |
| 2026-07-15 | PBYI | -1.13 | 6.34 | 9.43 |
| 2026-07-16 | PBYI | -1.13 | 6.34 | 9.43 |
| 2026-07-17 | PBYI | -1.13 | 6.34 | 9.43 |
| 2026-07-20 | PBYI | -1.13 | 6.43 | 9.43 |
| 2026-07-21 | PBYI | -1.13 | 6.43 | 9.43 |
| 2026-07-22 | PBYI | -1.13 | 6.43 | 9.43 |
| 2026-07-23 | PBYI | -1.13 | 6.43 | 9.43 |
| 2026-07-24 | PBYI | -1.13 | 6.43 | 9.43 |
| 2026-07-27 | PBYI | -1.13 | 6.37 | 10.16 |
| 2026-07-28 | PBYI | -1.13 | 6.37 | 10.16 |
| 2026-07-29 | PBYI | -1.13 | 6.37 | 10.16 |
| 2026-07-30 | PBYI | -1.13 | 6.37 | 10.16 |
| 2026-07-31 | PBYI | -1.13 | 6.37 | 10.16 |
| 2026-08-03 | PBYI | -1.13 | 6.34 | 10.16 |
| 2026-08-04 | PBYI | -1.13 | 6.34 | 10.16 |
| 2026-08-05 | PBYI | -1.13 | 6.34 | 10.16 |
| 2026-08-06 | PBYI | -1.13 | 6.34 | 10.16 |
| 2026-08-07 | PBYI | -1.13 | 6.34 | 10.16 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.07
Avg. EPS Est. Current Quarter
0.07
Avg. EPS Est. Next Quarter
0.19
Insider Transactions
-1.13
Institutional Transactions
6.34
Beta
1.22
Average Sales Estimate Current Quarter
53
Average Sales Estimate Next Quarter
61
Fair Value
10.38
Quality Score
96
Growth Score
36
Sentiment Score
76
Actual DrawDown %
-2.3
Max Drawdown 5-Year %
-78.6
Target Price
6
P/E
18.66
Forward P/E
44.55
PEG
P/S
2
P/B
3.53
P/Free Cash Flow
8.46
EPS
0.48
Average EPS Est. Cur. Y
0.45
EPS Next Y. (Est.)
0.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.73
Relative Volume
2.21
Return on Equity vs Sector %
-8.3
Return on Equity vs Industry %
7.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.05
EBIT Estimation
◆
PBYI
Healthcare
$8.91
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
67.3
Range 1M
69.5%
Sup Dist
11%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-52.5%
EPS NY
-31%
52W%
90.7%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-26% upside
Upside
-26%
Quality
96
MoS
16%
PBYI — P/E HistoricalBiotechnology
Puma Biotechnology IncSector: Healthcare
Industry: Biotechnology
Employees: 179
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. It sells its products through specialty pharmacy and distributor networks. The company has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
PBYI
Latest News
—
Caricamento notizie per PBYI…
stock quote shares PBYI – Puma Biotechnology Inc. Stock Price stock today
news today PBYI – Puma Biotechnology Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PBYI – Puma Biotechnology Inc. yahoo finance google finance
stock history PBYI – Puma Biotechnology Inc. invest stock market
stock prices PBYI premarket after hours
ticker PBYI fair value insiders trading